Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cong-Fei Xu

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Science Bulletin|December 10, 2023
In vivo production of CAR-T cells using virus-mimetic fusogenic nanovesiclesGui Zhao, Yue Zhang, Cong-Fei Xu, et al.
Advanced Healthcare Materials|April 19, 2021
Biomaterials-Based Delivery of Therapeutic Antibodies for Cancer TherapyQian-Ni Ye, Yue Wang, Song Shen, et al.
Advanced Drug Delivery Reviews|April 12, 2017
Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to CancerYang Liu, Cong-Fei Xu, Shoaib Iqbal, et al.
Biomaterials|March 16, 2015
Targeting glucose uptake with siRNA-based nanomedicine for cancer therapyCong-Fei Xu, Yang Liu, Song Shen, et al.
ACS Applied Materials & Interfaces|June 15, 2021
Co-delivery of Phagocytosis Checkpoint Silencer and Stimulator of Interferon Genes Agonist for Synergetic Cancer ImmunotherapyZi-Dong Lu, Yi-Fang Chen, Song Shen, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 19, 2019
Development of "CLAN" Nanomedicine for Nucleic Acid TherapeuticsCong-Fei Xu, Shoaib Iqbal, Song Shen, et al.
Biomaterials Science|May 5, 2018
Systemic delivery of CRISPR/Cas9 with PEG-PLGA nanoparticles for chronic myeloid leukemia targeted therapyYang Liu, Gui Zhao, Cong-Fei Xu, et al.
Angewandte Chemie (International Ed. in English)|January 13, 2016
Facile Generation of Tumor-pH-Labile Linkage-Bridged Block Copolymers for Chemotherapeutic DeliveryChun-Yang Sun, Yang Liu, Jin-Zhi Du, et al.
Biomaterials|May 4, 2018
Optimization of lipid-assisted nanoparticle for disturbing neutrophils-related inflammationYang Liu, Zhi-Ting Cao, Cong-Fei Xu, et al.
Nature Communications|April 8, 2023
Engineering tumor-specific gene nanomedicine to recruit and activate T cells for enhanced immunotherapyYue Wang, Shi-Kun Zhou, Yan Wang, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Science Bulletin|December 10, 2023
In vivo production of CAR-T cells using virus-mimetic fusogenic nanovesiclesGui Zhao, Yue Zhang, Cong-Fei Xu, et al.
Advanced Healthcare Materials|April 19, 2021
Biomaterials-Based Delivery of Therapeutic Antibodies for Cancer TherapyQian-Ni Ye, Yue Wang, Song Shen, et al.
Advanced Drug Delivery Reviews|April 12, 2017
Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to CancerYang Liu, Cong-Fei Xu, Shoaib Iqbal, et al.
Biomaterials|March 16, 2015
Targeting glucose uptake with siRNA-based nanomedicine for cancer therapyCong-Fei Xu, Yang Liu, Song Shen, et al.
ACS Applied Materials & Interfaces|June 15, 2021
Co-delivery of Phagocytosis Checkpoint Silencer and Stimulator of Interferon Genes Agonist for Synergetic Cancer ImmunotherapyZi-Dong Lu, Yi-Fang Chen, Song Shen, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 19, 2019
Development of "CLAN" Nanomedicine for Nucleic Acid TherapeuticsCong-Fei Xu, Shoaib Iqbal, Song Shen, et al.
Biomaterials Science|May 5, 2018
Systemic delivery of CRISPR/Cas9 with PEG-PLGA nanoparticles for chronic myeloid leukemia targeted therapyYang Liu, Gui Zhao, Cong-Fei Xu, et al.
Angewandte Chemie (International Ed. in English)|January 13, 2016
Facile Generation of Tumor-pH-Labile Linkage-Bridged Block Copolymers for Chemotherapeutic DeliveryChun-Yang Sun, Yang Liu, Jin-Zhi Du, et al.
Biomaterials|May 4, 2018
Optimization of lipid-assisted nanoparticle for disturbing neutrophils-related inflammationYang Liu, Zhi-Ting Cao, Cong-Fei Xu, et al.
Nature Communications|April 8, 2023
Engineering tumor-specific gene nanomedicine to recruit and activate T cells for enhanced immunotherapyYue Wang, Shi-Kun Zhou, Yan Wang, et al.
Pageof 4